Amazon Business meets healthcare – digital encroachment of hospital network supply chains

Supply chain offerings to hospital networks by medical distributors have been helped and hurt by digitization. For distributors like Owens and Minor, Amazon Business is here to hurt.

Supply chain dynamics within healthcare delivery networks are complicated by the fact that demand forecasts are often more difficult to predict, given that demand is typically not driven by market dynamics determined by discretionary spending.  Patients are considered a form of consumer, but their behavior is dissimilar from most material consumers in that their consumption of healthcare resources is most often not by choice.  Even when demand driven by patients’ decision-making is predictable, the logistics of offering drugs, devices and services tends to require specialized means of delivery by suppliers like Owens & Minor.

Digitization of supply chain management by delivery systems through Electronic Data Interchange (EDI) initially benefitted the bottom line of medical device suppliers like Owens & Minor, a firm that was featured in 2002 by a Harvard Business School case study for its adoption of Activity-Based Costing (ABC).  Hospital system mergers under the managed care momentum of the 1990s caused consolidation of demand that drove down the already-thin margins of Owens & Minor, while EDI improved demand forecasting.  Suppliers, seeing hospital systems work directly with manufacturers to order high-margin items and avoid paying a percentage to distributors, adopted EDI and offered just-in-time (JIT) delivery of goods (even intra-operatively) to avoid being cut out as middlemen.  Of late, however, Owens & Minor has faced equal pressures from fully-digitized supply chain marketplaces, such as Amazon Business, which launched in 2015 to attract 45,000 sellers of 5 million differentiated products and offers benefits akin to Amazon’s consumer-facing counterpart – same day shipping, free 2-day shipping for certain purchases, and possible sales tax exemptions (1).  Rather than representing competitive pressures of consolidated hospital networks working directly with manufacturers to secure higher margin items at cost, Amazon Business represents a competitive pressure that willingly assumes supply responsibility for the high-volume, low margin sales with which Owens & Minor has been left.

Owens & Minor has admitted to this “ongoing margin pressure” as recently as Q1 2017 when its revenue and gross margin both dropped 5.2%, prompting CEO P. Cody Phipps to outline a 4 part strategy that includes “the most intelligent route to market, expanding along the continuum of care, becoming the preferred outsourcer for leading manufacturers, and leveraging our data, analytics, and services” (2).  O&M management’s short-term response to Amazon’s digital presence in the supply chain has been similar to that of many businesses in diverse industries as Amazon has encroached (the ‘Amazon effect’) – join rather than fight.  O&M and other medical suppliers have started to sell such low-margin, high volume items as catheters, syringes, infusion pumps, forceps, scalpels, sutures and even hospital beds.  Looking forward 10 years, O&M may choose to continue to outsource distribution of such product types to Amazon Business while focusing on higher margin items that require idiosyncratic means of storage and delivery due to their fragile or perishable nature.  In other words, digitization via electronic data interchanges (EDIs) with hospitals in the late 1990s improved Owen & Minor’s competitiveness in a consolidating industry by reducing their exposure to the ‘bullwhip effect’ of supply/demand mismatches with provider groups (3).  Now, hospital networks ordering high volume, low margin items from the best bidder on the digital marketplace of Amazon Business has left O&M vulnerable to competitive pressure on both ends of the pricing spectrum.

Going forward, Owens & Minor’s executive leadership will need to review their strategy of outsourcing low-margin, high volume delivery to Amazon Business, as a general movement toward value-based healthcare and continued consolidation of healthcare networks will reward those suppliers who are best able to offer insight to networks into reducing waste upstream of the point of care (4).  Indeed, Owens & Minor’s strategic move from cost-plus pricing to activity-based pricing has provided valuable information to partnerships with hospital networks on what items should and should not require JIT delivery, large-volume delivery, or specialized storage due to high-spoilage rates.  First, O&M should focus on strengthening its existing contracts and pricing relationships with hospital networks by building its own EDIs to embolden provider groups’ cost containment efforts.  Second, O&M should offer more appealing revenue-sharing agreements to manufacturers of low volume, high margin items in order to maintain supply through the supply chain and deter hospital networks from ostracizing distributors in the supply chain.  Finally, O&M should direct its marketing efforts toward accountable care organizations (ACOs) that require greater value out of the supply chain and stand to benefit most from a vertically integrated, fully digitized supplier that focuses on cost efficiency.

Still, O&M’s efforts will not address the growing trend of consumerism by patients – has the ‘Amazon effect’ created such brand equity that patients will demand more medical delivery direct-to-consumer by their favorite digital marketplace, be it to their clinics, long-term care facilities, or their homes? (789 words)

 

(1) Kacik, Alex. “Amazon poised to deliver disruption in medical supply industry.” Modern Healthcare, June 10, 2017. http://www.modernhealthcare.com/article/20170610/MAGAZINE/170609923

(2) Investor press release by Owens & Minor. “Owens & Minor Outlined its New Strategic Plan and Reaffirmed its Financial Outlook for 2017 and 2018 at Annual Investor Meeting,” March 16, 2017. http://investors.owens-minor.com/releasedetail.cfm?releaseid=1017649

(3) Narayanan, V.C. & Brem, L. “Owens & Minor, Inc.” HBS No. 9-100-055. Boston: Harvard Business School Publishing,  Feb, 14, 2002.

(4) “Amazon’s shaking up the medical supply business. Here’s how we’re thinking about it.” Advisory Board Company, July 15, 2017. https://www.advisory.com/daily-briefing/2017/06/15/amazon-medical-supplies#ABCtake

Previous:

Kisses Good-bye….Chocolate shortage by 2030?

Next:

Shooting Oneself in the Foot(ball)

2 thoughts on “Amazon Business meets healthcare – digital encroachment of hospital network supply chains

  1. Great article @TOM4! I had to miss the Owens & Minor class for a doctor visit (ironically) so it was interesting to learn more about the company from your post. It looks like Amazon is disrupting yet another sector… no surprise there. As you discuss in the article, Owens & Minor will have to really understand what their competitive advantage to hospitals is in order to survive. While I was reading, I also thought about how digitization is making waves in hospital pharmaceutical supply chains, including new trace-ability regulations (see http://www.tracelink.com for an example of a business that is capitalizing on this shift). Perhaps, like TraceLink, Owens & Minor can survive and even beat out Amazon by focusing on quality control within a very specific part of the medical supply chain.

  2. Very interesting! Another significant area where Amazon may disrupt the healthcare supply chain is in the pharmacy space. Their strong distribution channels and good customer relationships provide a baseline infrastructure that could allow them to take on pharmacy distribution. To this end, they have already begun buying pharmacy licenses in multiple states. Further down the road, they could also be a position to acquire or take on the pharmacy benefit managers (PBMs) and also move from selling and distributing drugs into provision of a pharmacy insurance benefit.

    Source: https://www.nytimes.com/2017/10/27/technology/amazon-pharmacy-drugs.html?_r=0

Leave a comment